Jarunee Vanichtanankul

Jarunee Vanichtanankul

Auto-generated profile, based on publicly available information

Jarunee Vanichtanankul

National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Thailand Science Park, Pathumthani 12120, Thailand

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2022 in ACS Chemical Biology
Verified
Journal Article
Closed access
JVJarunee Vanichtanankul
Jarunee Vanichtanankul
AYAphisit Yoomuang
Aphisit Yoomuang
STSupannee Taweechai
Supannee Taweechai
TSThanaya Saeyang
Thanaya Saeyang
JPJutharat Pengon
Jutharat Pengon
SKSumalee Kamchonwongpaisan
Sumalee Kamchonwongpaisan

9 January 2024 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
IAIbrar Alam
Ibrar Alam
TBThitikorn Boonkoom
Thitikorn Boonkoom
HPHarit Pitakjakpipop
Harit Pitakjakpipop
PBPoramin Boonbanjong
Poramin Boonbanjong
KLKawin Loha
Kawin Loha
DJDeanpen Japrung
Deanpen Japrung

1 January 2022 in Structure
Verified
Journal Article
Closed access
Duangrudee TanramlukDuangrudee Tanramluk
Duangrudee Tanramluk
DPDanaya Pakotiprapha
Danaya Pakotiprapha
SPSakao Phoochaijaroen
Sakao Phoochaijaroen
PCPattra Chantravisut
Pattra Chantravisut
STSirikanya Thampradid
Sirikanya Thampradid
JYJirundon Yuvaniyama
Jirundon Yuvaniyama

2 November 2022 in ChemMedChem
Verified
Journal Article
Open access
KSKhonzisizwe Somandi
Khonzisizwe Somandi
TSTswene D. Seanego
Tswene D. Seanego
TMTebogo Dlamini (Née Molatsane)
Tebogo Dlamini (Née Molatsane)
MMMatthew Maree
Matthew Maree
CKCharles B. de Koning
Charles B. de Koning
ARAmanda L. Rousseau
Amanda L. Rousseau
A series of 5‐[(phenethylamino)methyl]pyrimidine‐2,4‐diamines were assessed in silico as potential inhibitors of Plasmodium falciparum dihydrofolate reductase (PfDHFR), synthesised and tested for inhibitory activity against PfDHFR in vitro. The compounds displayed promising inhibitory activity against both wild‐type (Ki 1.3–243 nM) and quadruple mutant (Ki 13–208 nM) PfDHFR in the biochemical enzyme assay, but were less potent in the whole‐cell P. falciparum assay (IC50(TM4/8.2) 0.4–28 μM; IC50(V1S) 3.7–54 μM). Further investigation into the pharmacokinetic properties of these compounds may guide the development of more potent analogues.

3 September 2024 in Bioorganic Chemistry
Verified
Journal Article
Closed access
SDSasithorn Decharuangsilp
Sasithorn Decharuangsilp
UAUthai Arwon
Uthai Arwon
MHMarie Hoarau
Marie Hoarau
JVJarunee Vanichtanankul
Jarunee Vanichtanankul
TSThanaya Saeyang
Thanaya Saeyang
YYYongyuth Yuthavong
Yongyuth Yuthavong

14 July 2025 in ACS Omega
Verified
Journal Article
Open access
CAChanya Archapraditkul
Chanya Archapraditkul
JVJarunee Vanichtanankul
Jarunee Vanichtanankul
TSThanaya Saeyang
Thanaya Saeyang
WCWireeya Chawjiraphan
Wireeya Chawjiraphan
PBPoramin Boonbanjong
Poramin Boonbanjong
DJDeanpen Japrung
Deanpen Japrung
Human serum albumin (HSA) is a key biomarker for early detection of kidney disorders such as microalbuminuria. However, its structural complexity and susceptibility to degradation in urine challenge current diagnostic assays, particularly immunoturbidimetric methods that depend on epitope stability. In this study, we expressed and characterized full-length recombinant HSA (rHSA) and its proteolytic fragment F8 (residues 496–585) in both Escherichia coli and rice-based systems to explore their suitability for biosensor validation and diagnostic use. Comparative analysis via SDS-PAGE, LC–MS/MS, and dynamic light scattering revealed differences in solubility and aggregation profiles between expression systems, with rice-derived rHSA showing greater resistance to proteolytic degradation. The F8 fragment retained structural integrity and remained detectable in both native and protease-treated samples. Using a previously developed Cy5-labeled ssDNA aptamer-based fluorescence aptasensor, we evaluated binding to rHSA and F8 across a clinically relevant concentration range (0.37–1500 μg/mL). Sigmoidal fluorescence recovery curves with R2 > 0.99 were observed for all recombinant proteins. Notably, the aptasensor successfully detected both targets even under conditions mimicking nonfresh urine, highlighting its diagnostic robustness. These findings establish recombinant F8 as a stable, diagnostically relevant biomarker candidate and confirm the practical utility of aptamer-based platforms for albumin detection in diverse testing scenarios.